intravenous vitamin c for infection

I am Jeanne Drisko, MD, a professor emeritus at the University of Kansas Medical Center. I have spent my academic career conducting translational research in intravenous vitamin C. Today we will clear up outdated misconceptions and old prejudices that have followed the use of intravenous vitamin C for cancer. When vitamin C is given in the vein it bypasses tight control of absorption at the gut and becomes a drug. While it may retain some of its vitamin-like properties, it now becomes a drug and a prooxidant. As with any drug, dosing and infusion rates are critical. The practice of intravenous vitamin C will be more understandable for practitioners and patients alike. 

Dr. Michael J. Gonzalez is Professor at the Nutrition Program, School of Public Health in the Medical Sciences Campus, University of Puerto Rico and Adjunct faculty at the Universidad Central del Caribe. Dr. Gonzalez is a Fellow of the American College of Nutrition, and has authored over 250 scientific publications. He has serve as a member on several scientific Editorial Boards. He has served as consultant for several companies where he has been responsible for designing formulations of nutritional supplements and pharmaceutical products. He is in a part time clinical practice with Dr. Miguel J Berdiel in Ponce, PR. In December 2013, Dr. Gonzalez was exalted as Distinguished Ponceño in the area of Medicine, due to his contributions in various areas of nontoxic disease therapy. In 2015 he was selected as member to the prestigious Puerto Rican Academy of Arts and Sciences and to the Iberoamerican Academy of Culture and Sciences.

Dr Gonzalez is internationally recognized for his research and writings regarding intravenous vitamin C for cancer, infections, and chronic disease.  Michael discusses his use of IV C and other natural therapies in detail today.